Latest 8-K filings

Purple Innovation, Inc. has officially filed a Certificate of Amendment to implement a 1-for-25 reverse stock split, effective July 19, 2026, with trading on a split-adjusted basis commencing July 20, 2026.

Cardiff Oncology announced a $10 million registered direct offering of common stock and warrants to fund working capital and general corporate purposes.

Gevo, Inc. announced the appointment of Todd Werpy, Ph.D. to its Board of Directors, effective August 20, 2026, bringing extensive experience in sustainable technologies and executive leadership.

Harmony Biosciences announced preliminary record net product revenue of approximately $261 million for Q2 2026, a 30% year-over-year increase, and reaffirmed its full-year revenue guidance.

Sadot Group Inc. has entered into a settlement agreement with Helena Global Investment Opportunities I Ltd. to resolve a lawsuit concerning alleged breaches of financing agreements.

Etsy and eBay have amended their sale agreement for Depop, setting a closing date of July 30, 2026, following UK regulatory approval.

Vivani Medical announced an updated timeline for its SLIM-1 first dosing, now expected in August 2026, during a presentation at the Emerging Growth Conference.

New Horizon Aircraft Ltd. announced its fiscal year 2026 results, highlighting a strengthened balance sheet with $78.3 million in cash and continued progress on its Cavorite X7 VTOL aircraft development.

Sharon AI announced a significant five-year cloud computing infrastructure agreement valued at US$1.32 billion with a global Artificial Intelligence Lab.

enGene Therapeutics announces board leadership changes and outlines upcoming regulatory and commercial plans for its lead drug candidate, detalimogene.

CDT Equity Inc. is implementing a 1-for-10 reverse stock split to maintain compliance with Nasdaq's bid-price rule, effective July 17, 2026.

Prologis reported strong Q2 2026 results, exceeding expectations and raising full-year guidance, driven by record leasing activity and improving operational fundamentals.

TOMI Environmental Solutions, Inc. will implement a one-for-three reverse stock split of its common and preferred stock, effective July 20, 2026.

Edgewise Therapeutics files an 8-K/A to amend its previous report, providing pro forma financial information following the $1.55 billion sale of its sevasemten muscular dystrophy program to Servier Pharmaceuticals.

Bank7 Corp. announced its second quarter 2026 financial results, reporting a decrease in net income and EPS, but an increase in total assets and loans, alongside a successful recovery from a prior energy loan.

NextBoat Inc. announced record second quarter performance with significant growth in transaction volume and progress toward profitability, leading to an upward revision of its third quarter guidance.

Forum Markets, Inc. has acquired a CFM56-7B aircraft engine for $11.65 million, expanding its aviation portfolio and generating immediate lease revenue.

Gain Therapeutics announced its cash and cash equivalents are projected to fund operations into Q2 2027, with key clinical trial milestones expected in late 2026.

The Allstate Corporation announced estimated catastrophe losses for June 2026 totaling $563 million, with second quarter losses reaching $1.72 billion.

Gibraltar Industries has finalized the sale of its Renewables racking and foundations business to Unirac for $5 million, completing its strategic exit from the renewables sector.

Trilogy Metals Inc. announced the publication of a coordinated federal and state permitting schedule for its Arctic Project, targeting a Record of Decision by September 2028.

Abbott Laboratories announced strong second-quarter 2026 financial results, with reported sales up 13.0% and comparable sales up 4.8%, while raising its full-year adjusted diluted EPS guidance.

Arbutus Biopharma announced receipt of $178M from Moderna settlement, initiated patent lawsuits against Pfizer/BioNTech, and plans to return up to $230M to shareholders.

Soluna Holdings, Inc. has appointed Ryan Carver, formerly of Microsoft, as its new Chief Development Officer to accelerate the expansion of its AI infrastructure platform.

State Street Corporation announced robust second-quarter 2026 financial results, showcasing record revenues and assets under custody and administration.

ManpowerGroup announced robust second quarter 2026 results, with revenues increasing 8% year-over-year to $4.9 billion, driven by strong demand across key markets and improved performance in its Experis and Talent Solutions brands.

Eli Lilly and Company announced a definitive agreement to acquire AtaiBeckley Inc. for $6.75 per share in cash plus a contingent value right (CVR) for potential future payments.

Insmed announces positive 12-month safety and efficacy data from its open-label extension study of treprostinil palmitil inhalation powder (TPIP) in patients with pulmonary arterial hypertension (PAH).

FirstCash Holdings, Inc. has revised its cash offer to acquire Ramsdens Holdings PLC, increasing the total consideration to approximately £232 million.

U.S. Bancorp announced record net revenue of $7.7 billion and a 22% year-over-year increase in diluted EPS to $1.35 for the second quarter of 2026.